Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Reagan

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Leukemia Research|August 13, 2013
Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortalityAnthony Pham, John L Reagan, Jorge J Castillo
The New England Journal of Medicine|November 18, 2020
Azacitidine and Venetoclax in AMLJozal W Moore, Aryeh Pelcovits, John L Reagan
British Journal of Haematology|April 25, 2018
Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomasAdam J Olszewski, Thomas Ollila, John L Reagan
Bone Marrow Transplantation|November 13, 2024
Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemiaMary R Christopher, Mariam T Nawas, John L Reagan
Clinical Neurology and Neurosurgery|September 16, 2020
Preliminary findings regarding the use of direct oral anticoagulants in cerebral venous thrombosisAndrew Hsu, Hetal Mistry, Nupur Lala, et al.
Rhode Island Medical Journal (2013)|July 26, 2022
Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient ManagementArun Muthiah, Sarah Ohnigian, John L Reagan, et al.
Cancer Medicine|October 1, 2019
Use of bone-modifying agents and clinical outcomes in older adults with multiple myelomaAdam J Olszewski, Peter M Barth, John L Reagan
Clinical Lymphoma, Myeloma & Leukemia|January 24, 2018
Mechanisms of Hypercalcemia in Non-Hodgkin Lymphoma and Associated Outcomes: A Retrospective ReviewRory M Shallis, Rachel S Rome, John L Reagan
Leukemia & Lymphoma|July 10, 2019
Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data BaseThomas A Ollila, John L Reagan, Adam J Olszewski
American Journal of Hematology|September 30, 2017
Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomasAdam J Olszewski, John L Reagan, Jorge J Castillo
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Leukemia Research|August 13, 2013
Multiple myeloma-induced hyperammonemic encephalopathy: an entity associated with high in-patient mortalityAnthony Pham, John L Reagan, Jorge J Castillo
The New England Journal of Medicine|November 18, 2020
Azacitidine and Venetoclax in AMLJozal W Moore, Aryeh Pelcovits, John L Reagan
British Journal of Haematology|April 25, 2018
Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomasAdam J Olszewski, Thomas Ollila, John L Reagan
Bone Marrow Transplantation|November 13, 2024
Molecular measurable residual disease monitoring and transplant indications in NPM1 mutated acute myeloid leukemiaMary R Christopher, Mariam T Nawas, John L Reagan
Clinical Neurology and Neurosurgery|September 16, 2020
Preliminary findings regarding the use of direct oral anticoagulants in cerebral venous thrombosisAndrew Hsu, Hetal Mistry, Nupur Lala, et al.
Rhode Island Medical Journal (2013)|July 26, 2022
Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient ManagementArun Muthiah, Sarah Ohnigian, John L Reagan, et al.
Cancer Medicine|October 1, 2019
Use of bone-modifying agents and clinical outcomes in older adults with multiple myelomaAdam J Olszewski, Peter M Barth, John L Reagan
Clinical Lymphoma, Myeloma & Leukemia|January 24, 2018
Mechanisms of Hypercalcemia in Non-Hodgkin Lymphoma and Associated Outcomes: A Retrospective ReviewRory M Shallis, Rachel S Rome, John L Reagan
Leukemia & Lymphoma|July 10, 2019
Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data BaseThomas A Ollila, John L Reagan, Adam J Olszewski
American Journal of Hematology|September 30, 2017
Late infections and secondary malignancies after bendamustine/rituximab or RCHOP/RCVP chemotherapy for B-cell lymphomasAdam J Olszewski, John L Reagan, Jorge J Castillo
Pageof 8